APA (7th ed.) Citation

Fürstenau, M., Bahlo, J., Fink, A. M., Lange, E., Dreger, P., Dreyling, M., . . . Eichhorst, B. (2020). Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia. Leukemia, 34(3), . https://doi.org/10.1038/s41375-019-0597-3

Chicago Style (17th ed.) Citation

Fürstenau, Moritz, et al. "Residual Abdominal Lymphadenopathy After Intensive Frontline Chemoimmunotherapy Is Associated with Inferior Outcome Independently of Minimal Residual Disease Status in Chronic Lymphocytic Leukemia." Leukemia 34, no. 3 (2020). https://doi.org/10.1038/s41375-019-0597-3.

MLA (9th ed.) Citation

Fürstenau, Moritz, et al. "Residual Abdominal Lymphadenopathy After Intensive Frontline Chemoimmunotherapy Is Associated with Inferior Outcome Independently of Minimal Residual Disease Status in Chronic Lymphocytic Leukemia." Leukemia, vol. 34, no. 3, 2020, https://doi.org/10.1038/s41375-019-0597-3.